IGC Pharma, Inc. (IGC) compared with its closest peers (ATNM, LITS, MIRA, ACTU, LTRN). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | $34.90M | 3.0 |
| Lite Strategy, Inc. (LITS) | $34.02M | — |
| MIRA Pharmaceuticals, Inc. (MIRA) | $33.62M | -1.1 |
| Actuate Therapeutics Inc (ACTU) | $32.54M | -5.8 |
| Lantern Pharma Inc. (LTRN) | $30.17M | -1.9 |
| Daré Bioscience, Inc. (DARE) | $29.74M | -1.6 |
| BeyondSpring Inc. (BYSI) | $29.61M | -80.0 |
| NextCure, Inc. (NXTC) | $29.16M | -0.7 |
| NanoViricides, Inc. (NNVC) | $28.68M | -2.1 |
| Optimi Health Corp. (OPTH) | $27.43M | — |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
IGC overview · IGC earnings · IGC financials · IGC KPIs · IGC investor relations · IGC ownership · IGC filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.